Osaka, Japan

Satoru Kawatake

This inventor holds 1 USPTO granted patent. Top assignee: Shionogi Company Limited. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satoru Kawatake. Retrieved from https://idiyas.com/inventor/satoru-kawatake

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Satoru Kawatake: Innovator in Pharmaceutical Purification

Introduction

Satoru Kawatake is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the purification of cephalosporins. His innovative approach has led to advancements in the efficiency and effectiveness of drug purification processes.

Latest Patents

Kawatake holds a patent for a process titled "Purification of cephalosporins." This patent describes a method for purifying oxacephalosporins by contacting an aqueous solution of oxacephalosporin carboxylic acid with a macroporous polymeric adsorbent. The process effectively separates the oxacephalosporin carboxylic acid from non-adsorbable contaminants, enhancing the purity of the final product.

Career Highlights

Satoru Kawatake is associated with Shionogi Company Limited, where he applies his expertise in pharmaceutical research and development. His work has been instrumental in improving the quality of cephalosporin antibiotics, which are crucial in treating various bacterial infections.

Collaborations

Kawatake has collaborated with notable colleagues such as Hiroaki Koizumi and Kanji Tokuyama. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical sector.

Conclusion

Satoru Kawatake's contributions to the purification of cephalosporins highlight his role as an important figure in pharmaceutical innovation. His work continues to impact the industry positively, ensuring the availability of high-quality medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…